Hospital Acquired Infection Control Market

Hospital Acquired Infection Control Market - Global Forecast to 2022

Report Code: UC 1438 Dec, 2018, by marketsandmarkets.com

The hospital acquired infection control market is expected to witness a steady growth rate during the forecast period. The large-scale use of disinfectors and medical nonwovens in the healthcare industry, growing emphasis on infection control policies within hospital premises, rapidly growing geriatric population, and increasing number of surgeries performed across the globe are expected to propel the growth of this market. However, stringent regulatory requirements may restrain the growth of this market to a certain extent.

In this report, the global hospital acquired infection control market is segmented into infection prevention, infection testing, end user, and region. The infection prevention segment has been further segmented into sterilizers, disinfectors, endoscope reprocessors, and disinfectants. The disinfectants have been sub-segmented on the basis of type (hand disinfectants, skin disinfectants, instrument disinfectants, and surface disinfectants/ disinfectant robots) and by formulation (disinfectant wipes, disinfectant liquids, and disinfectant sprays). During the forecast period, the disinfectants accounted for the largest share of the market. This can be attributed to large scale use of a number of disinfectants across the healthcare industry.

Infection testing segment is further categorized on the basis of product, application, technology, and disease. Based on product, the infection testing market is segmented into microbial testing instruments (automated microbial identification systems, polymerase chain reaction (PCR) instruments, mass spectrometers, microarrays, polystainers, flow cytometers, and others), reagents and consumables, and infection prevalence and surveillance software. On the basis of application, the market is segmented into disease testing and drug-resistance testing. On the basis of technology, the market is segmented into phenotypic methods (phage-based assays, colorimetric methods, nitrate reductase assay) and genotypic methods (DNA sequencing, solid-phase hybridization techniques, polymerase chain reaction techniques, and microarrays).  Based on disease type, the market is segmented into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), and others.

On the basis of end user, the market is segmented into hospitals and intensive care units (ICUs), ambulatory surgical and diagnostic centers, nursing homes and maternity centers, and others. In 2016, the hospitals and ICUs accounted for the largest share of the global hospital acquired infection control market.

North America is the largest regional segment of the global hospital acquired infection control market. However, the APAC and Latin American regions are expected to witness significant growth in the coming years, primarily due to rising incidences of HAIs, growing number of hospitals, increasing medical tourism in emerging countries such as China and India, rising aging population with the resultant increase in the number of chronic disease cases.

Some of the major players in the global hospital acquired infection control market are Becton, Dickinson and Company (U.S.), Steris Corporation (U.S.), Advanced Sterilization Products (U.S., a division of Ethicon US, LLC), Getinge Group (Sweden), Kimberly-Clark Corporation (U.S.), Cantel Medical (U.S.), BioMérieux SA (France), Belimed AG (Switzerland), 3M company (U.S.), Sterigenics International LLC. (U.S.), and Synergy Health, plc (U.K.).

Scope of the Report:

The research report categorizes the global hospital acquired infection control market into the following segments and subsegments:

Global Hospital Acquired Infection Prevention Market, by Product

  • Sterilizers
  • Disinfectors
  • Endoscope Reprocessors
  • Disinfectants
    • Disinfectants Market, By Type
      • Hand Disinfectants
      • Skin Disinfectants
      • Instrument Disinfectants
      • Surface Disinfectants/Disinfectant Robots
    • Disinfectants Market, By Formulation
      • Disinfectant Wipes
      • Disinfectant Liquids
      • Disinfectant Sprays

Global Hospital Acquired Infection Testing Market

  • Hospital Acquired Infection Testing Market, By Product
    • Microbial Testing Instruments
      • Automated Microbial Identification Systems
      • Polymerase Chain Reaction (PCR) Instruments
      • Mass Spectrometers
      • Microarrays
      • Polystainers
      • Flow Cytometers
      • Others
    • Reagents and Consumables
    • Infection Prevention and Surveillance Software
  • Hospital Acquired Infection Testing Market, By Application
    • Disease Testing
    • Drug-resistance Testing
  • Hospital Acquired Infection Testing Market, By Technology
    • Phenotypic Methods
      • Phage-based Assays
      • Colorimetric Methods
      • Nitrate Reductase Assay
    • Genotypic Methods
      • DNA Sequencing
      • Solid-phase Hybridization Techniques
      • Polymerase Chain Reaction Techniques
      • Microarrays
  • Hospital Acquired Infection Testing Market, By Disease
    • Hospital acquired Pneumonia
    • Bloodstream infections
    • Surgical site infections
    • Gastrointestinal Infections
    • Urinary Tract infections (UTI)
    • Others

Global Hospital Acquired Infection Control Market, By End User

  • Hospitals and Intensive Care Units (ICUs)
  • Ambulatory Surgical and Diagnostic Centers
  • Nursing Homes and Maternity Centers
  • Others

Table of Contents

1 Introduction
    1.1 Objectives of the Study 
    1.2 Market Definition 
    1.3 Market Scope 
    1.4 Currency 
    1.5 Stakeholders 

2 Research Methodology
    2.1 Research Approach 
    2.2 Market Size Estimation 
    2.3 Market Breakdown and Data Triangulation 
    2.4 Market Share Estimation 
    2.5 Assumptions for the Study 

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction 
    5.2 Market Segmentation 
           5.2.1 Infection Prevention
           5.2.2 Infection Testing
    5.3 Key Market Dynamics 
           5.3.1 Key Market Drivers
           5.3.2 Key Market Restraints
           5.3.3 Key Market Opportunities
           5.3.4 Key Market Challenges

6 Industry Insights
    6.1 Industry Trends 
    6.2 Regulatory Analysis 4

Global Hospital Acquired Infection Control Market - Analysis & Forecast to 2022

7 Global Hospital Acquired Infection Prevention Market, By Product
    7.1 Sterilizers 
    7.2 Disinfectors 
    7.3 Endoscope Reprocessors 
    7.4 Disinfectants 
           7.4.1 Disinfectants Market, By Type
                    7.4.1.1 Hand Disinfectants
                    7.4.1.2 Skin Disinfectants
                    7.4.1.3 Instrument Disinfectants
                    7.4.1.4 Surface Disinfectants/Disinfectant Robots
           7.4.2 Disinfectants Market, By Formulation
                    7.4.2.1 Disinfectant Wipes
                    7.4.2.2 Disinfectant Liquids
                    7.4.2.3 Disinfectant Sprays
    7.5 Medical Nonwovens 

8 Global Hospital Acquired Infection Testing Market
    8.1 Hospital Acquired Infection Testing Market, By Product 
           8.1.1 Microbial Testing Instruments
                    8.1.1.1 Automated Microbial Identification Systems
                    8.1.1.2 Polymerase Chain Reaction (PCR) Instruments
                    8.1.1.4 Mass Spectrometers
                    8.1.1.5 Microarrays
                    8.1.1.6 Polystainers
                    8.1.1.7 Flow Cytometers
                    8.1.1.8 Others
           8.1.2 Reagents and Consumables
           8.1.3 Infection Prevention and Surveillance Software
    8.2 Hospital Acquired Infection Testing Market, By Application 
           8.2.1 Disease Testing
           8.2.2 Drug-Resistance Testing
    8.3 Hospital Acquired Infection Testing Market, By Technology 
           8.3.1 Phenotypic Methods
                    8.3.1.1 Phage-Based Assays
                    8.3.1.2 Colorimetric Methods
                    8.3.1.3 The Nitrate Reductase Assay
           8.3.2 Genotypic Methods
                    8.3.2.1 Dna Sequencing
                    8.3.2.2 Solid-Phase Hybridization Techniques
                    8.3.2.3 Polymerase Chain Reaction Techniques
                    8.3.2.4 Microarrays 5
Global Hospital Acquired Infection Control Market - Analysis & Forecast to 2022
    8.4 Hospital Acquired Infection Testing Market, By Disease 
           8.4.1 Hospital Acquired Pneumonia
           8.4.2 Bloodstream Infections
           8.4.3 Surgical Site Infections
           8.4.4 Gastrointestinal Infections
           8.4.5 Urinary Tract Infections (UTI)
           8.4.6 Others

9 Global Hospital Acquired Infection Control Market, By End User
    9.1 Hospitals and Intensive Care Units (ICUS) 
    9.2 Ambulatory Surgical and Diagnostic Centers 
    9.3 Nursing Homes and Maternity Centers 
    9.4 Others 

10 Geographic Analysis
     10.1 North America 
             10.1.1 U.S.
             10.1.2 Canada
     10.2 Europe 
             10.2.1 Germany
             10.2.2 U.K.
             10.2.3 France
             10.2.4 Italy
             10.2.5 Spain
             10.2.6 Rest of Europe
     10.3 Asia-Pacific 
             10.3.1 Japan
             10.3.2 China
             10.3.3 India
             10.3.4 Rest of Asia-Pacific
     10.4 Latin America 
     10.5 Middle East & Africa 

11 Competitive Landscape
     11.1 Market Share Analysis (2016) 
     11.2 Competitive Benchmarking 
     11.3 Recent Developments 
             11.3.1 New Product Launch
             11.3.2 Agreements, Partnerships, Collaborations & Contracts
             11.3.3 Mergers & Acquisitions
             11.3.4 Expansion
             11.3.5 Others 6

Global Hospital Acquired Infection Control Market - Analysis & Forecast to 2022

12 Company Profiles
     12.1 Advanced Sterilization Products ( Division Ethicon Us, LLC ) 
     12.2 Becton, Dickinson and Company 
     12.3 Steris Corporation 
     12.4 Getinge Group 
     12.5 Kimberly-Clark Corporation 
     12.6 Cantel Medical 
     12.7 Biomerieux Sa 
     12.8 Belimed AG 
     12.9 3M Company 
     12.10 Sterigenics International LLC. 
     12.11 Synergy Health, PLC 

13 Appendix

*From the List of Companies Mentioned Above, Only Top 10 Companies Will Be Profiled in the Study.
*The List of Companies Mentioned Above is Indicative Only and Might Change During the Course of the Study
*Details on Key Financials and Growth Strategy Might Not Be Captured in Case of Unlisted Companies.
*SWOT Analysis and MnM View Will Be Provided for Top-5 Companies Only


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1438
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Hospital Acquired Infection Control Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved